Purified bivalent hemorrhagic fever with renal syndrome vaccine (VERO cells)(Changchun Bailong)

双价肾综合征出血热纯化疫苗（VERO细胞）（长春百龙）

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePurified bivalent hemorrhagic fever with renal syndrome vaccine (VERO cells)(Changchun Bailong)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHemorrhagic Fever with Renal Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesChangchun Bailong Bio-Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChangchun Bailong Bio-Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsHemorrhagic Fever with Renal Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A